Three Klebsiella species cause life-threatening infections and share drug resistance genes

August 2, 2017, American Society for Microbiology

A team of US researchers has discovered that three different species of Klebsiella bacteria can cause life-threatening infections in hospital patients and that all three share genes that confer resistance to the most commonly used antibiotics. The study, published this week in mSphere, an open-access journal of the American Society for Microbiology, improves physicians' understanding of Klebsiella infections and could point toward better ways to fight multi-drug resistant strains of these bacteria.

"Since 2001, we've seen a global explosion of drug-resistant Klebsiella infections," says S. Wesley Long, Associate Medical Director of the Diagnostic Microbiology Lab at Houston Methodist Hospital in Texas and lead author of the study. "They are drug-resistant bacteria that are increasingly difficult to treat because they are resistant to many of the available ."

Klebsiella are a type of bacteria that cause healthcare-associated infections, which can take the form of pneumonia, sepsis, wound infections and . Healthcare-associated infections numbered more than 700,000 in the US in 2011 and up to 50 percent of invasive , multidrug-resistant K. pneumoniae infections have been fatal in some studies. In the last two decades, antibiotic-resistant Klebsiella infections have been on the rise around the world.

Long and his team wanted to investigate the nature of Klebsiella infections by studying a large, comprehensive, population-based sample collection. "We need to understand the pathogen on a population level, then we can use the bacterial genomes to predict virulence or antibiotic resistance of the strain, or mortality," notes Long, a clinical microbiologist.

In a study previously published in mBio, the researchers sequenced the entire genome of 1,777 Klebsiella from clinical specimens across the greater Houston area. Until now, Klebsiella pneumoniae was thought to be the culprit in most serious Klebsiella infections. However, the research team noticed a group of 28 samples that looked genetically different.

"We built a genetic family tree, essentially, and 28 strains stick off the tree as outliers. These are cousins five times removed and we wondered what are these guys doing at the family reunion?" says Long.

It turned out that, depending on the collection, between 2-12 percent of the samples had been misidentified as Klebsiella pneumoniae, and were in fact two related species, Klebsiella variicola or Klebsiella quasipneumoniae. K. variicola and K. quasipneumoniae had previously been characterized as commensal, nonpathogenic bacteria of the GI tract or agricultural pests, which rarely caused . Long's team found they were capable of causing invasive and severe infections in patients, with the same rate of mortality as K. pneumoniae.

"Not only are these cousins of K. pneumoniae causing similar infections, but they are also sharing these powerful drug resistance genes," says Long. The sequencing of all bacterial genetic material present showed that all three Klebsiella species were sharing drug-resistance genes amongst themselves—including at least two genes that code for powerful enzymes that disable a broad spectrum of penicillin-like antibiotics.

Long says that these findings will not likely change the way Klebsiella infections are treated. "But in the race of trying to understand pathogens and find new antibiotics, or therapies outside the box of traditional antibiotics, this expands our knowledge of what pathogenic Klebsiella look like." Other genetic traits that the three Klebsiella species share might be exploited as an Achilles' heel weakness and attacked by new, targeted therapies. Long also says the work stresses the importance of doing large, comprehensive, population-based studies that take a close genetic look at patient samples: "If you are not looking, you don't know what you're missing."

Explore further: Scientists discover uncommon superbug strain in greater Houston area

Related Stories

Scientists discover uncommon superbug strain in greater Houston area

May 16, 2017
Houston Methodist Research Institute scientists used genome sequencing to discover that an otherwise rare strain of a superbug was found in more than one-third of the Houston patients studied. This strain is resistant to ...

NIH advances understanding of defenses against antibiotic-resistant klebsiella bacteria

January 25, 2017
Klebsiella bacteria cause about 10 percent of all hospital-acquired infections in the United States. K. pneumoniae sequence type 258 (ST258) is one of the Carbapenem-Resistant Enterobacteriaceae organisms labeled an urgent ...

Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria

November 10, 2016
Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS), Clinical Center and National Institute of Allergy and Infectious Diseases (NIAID) have created a new way to ...

Planning for bacteria in cancer patients may help hospitals fight infections

January 23, 2013
What cancerous conditions lead to what kinds of bacterial infections? If doctors knew, they could predict which patients would likely benefit from pre-treatment with certain kinds of antibiotics. A University of Colorado ...

Ineffective antibiotics form strong teams against deadly super bacteria

May 24, 2017
In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.

Research suggests retail meat is a potential vehicle for disease-causing Klebsiella

July 23, 2015
Chicken, turkey and pork sold in grocery stores harbors disease-causing bacteria known as Klebsiella pneumoniae, according to a new study. The research, which was published online today in the journal Clinical Infectious ...

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.